Iodide

Iodide

SCHEMBL1758281

CCCCCCCn1cc[n+](C)c1.[I-]

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.93
HSP90AA1 P07900 2/20 0.93
KMT2A Q03164 2/20 0.93
SMN1; SMN2 Q16637 2/20 0.93
APAF1 O14727 1/20 0.93
NPC1 O15118 1/20 0.93
PLA2G1B P04054 1/20 0.93
MAPT P10636 1/20 0.93
MAPK1 P28482 1/20 0.93
HTT P42858 1/20 0.93
RAB9A P51151 1/20 0.93
NPSR1 Q6W5P4 1/20 0.93
ATG4B Q9Y4P1 1/20 0.93
FDPS P14324 16/20 0.43
TBXAS1 P24557 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL594561 1.00 MEN1 (0.93) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Iodide SCHEMBL1219508 1.00 MEN1 (0.93) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Iodide SCHEMBL5087098 1.00 MEN1 (0.93) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Iodide SCHEMBL5091915 1.00 MEN1 (0.93) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Iodide SCHEMBL926313 1.00 MEN1 (0.93) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Iodide SCHEMBL5085005 1.00 MEN1 (0.93) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Iodide SCHEMBL2125637 1.00 MEN1 (0.93) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Iodide SCHEMBL1735056 1.00 MEN1 (0.93) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Iodide SCHEMBL5088502 1.00 MEN1 (0.93) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Hydrochloric Acid SCHEMBL29429158 0.98 MEN1 (0.89) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2790197-A2 Electrolyte for dye sensitized solar cell and dye sensitized solar cell using the same Samsung SDI Co., Ltd. (KR) 2014-10-15 EP claimed
US-20140299190-A1 ELECTROLYTE FOR DYE SENSITIZED SOLAR CELL AND DYE SENSITIZED SOLAR CELL USING THE SAME SAMSUNG SDI CO., LTD. (KR) 2014-10-09 US claimed
US-20110100461-A1 ELECTROLYTE COMPOSITION AND DYE-SENSITIZED SOLAR CELL HAVING THE SAME EVERLIGHT USA, INC. (US) 2011-05-05 US claimed
US-20110100464-A1 Electrolyte composition and dye-sensitized solar cell using the same EVERLIGHT USA, INC. (US) 2011-05-05 US claimed
US-12540715-B2 Lighting diffuser plate for collecting and recycling light energy, and lighting apparatus system comprising same DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2026-02-03 US disclosed
US-20250216053-A1 LIGHTING DIFFUSER PLATE FOR COLLECTING AND RECYCLING LIGHT ENERGY, AND LIGHTING APPARATUS SYSTEM COMPRISING SAME DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) 2025-07-03 US disclosed
WO-2023048350-A1 LIGHTING DIFFUSER PLATE FOR COLLECTING AND RECYCLING LIGHT ENERGY, AND LIGHTING APPARATUS SYSTEM COMPRISING SAME 동국대학교 산학협력단 2023-03-30 WO disclosed
EP-2790197-A2 Electrolyte for dye sensitized solar cell and dye sensitized solar cell using the same Samsung SDI Co., Ltd. (KR) 2014-10-15 EP disclosed
US-20140299190-A1 ELECTROLYTE FOR DYE SENSITIZED SOLAR CELL AND DYE SENSITIZED SOLAR CELL USING THE SAME SAMSUNG SDI CO., LTD. (KR) 2014-10-09 US disclosed
US-20140291166-A1 METHOD AND KIT FOR ELECTROCHEMICALLY DETECTING ANALYTE SYSMEX CORPORATION (JP) 2014-10-02 US disclosed
CN-102977321-A compound for solar cell electrolyte, preparation method thereof, electrolyte containing compound and solar cell EVERLIGHT CHEM IND CORP 2013-03-20 CN disclosed
US-20130056075-A1 COMPOUNDS FOR USE IN ELECTROLYTE FOR SOLAR CELL, METHOD FOR PREPARING THE SAME, AND ELECTROLYTE AND SOLAR CELL HAVING THE SAME EVERLIGHT USA, INC. (US) 2013-03-07 US disclosed
CN-102446630-A Electrolyte composition and dye-sensitized solar cell using same ETHICAL INTERNAT TRADING & WAREHOUSING SHANGHAI CO LTD 2012-05-09 CN disclosed
CN-102347138-A Electrolyte composition for dye-sensitized solar cell and solar cell using same EVERLIGHT CHEMICAL IND CO LTD 2012-02-08 CN disclosed
US-20110100461-A1 ELECTROLYTE COMPOSITION AND DYE-SENSITIZED SOLAR CELL HAVING THE SAME EVERLIGHT USA, INC. (US) 2011-05-05 US disclosed
US-20110100464-A1 Electrolyte composition and dye-sensitized solar cell using the same EVERLIGHT USA, INC. (US) 2011-05-05 US disclosed
US-20080214386-A1 Stability; easily separated from solution; surface treatment of catalyst with Group seven compound; reacting epoxide with carbon dioxide NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130056075-A1 COMPOUNDS FOR USE IN ELECTROLYTE FOR SOLAR CELL, METHOD FOR PREPARING THE SAME, AND ELECTROLYTE AND SOLAR CELL HAVING THE SAME HCN2, SCNN1A, HCN1 MEN1 98/4885HSP90AA1 4875/4885KMT2A 1712/4885
US-12540715-B2 Lighting diffuser plate for collecting and recycling light energy, and lighting apparatus system comprising same SOD1, SLC30A7, SLC39A7 MEN1 613/4885HSP90AA1 4260/4885KMT2A 4067/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.